John Herberger is currently Director of Process Development at Amgen Inc. Mr. Herberger joined Amgen in 1997 and has held numerous leadership roles in Drug Delivery/Formulation, Device Development, Technology Transfer (Drug Product & Drug Substance) and Global Operations. With over 25 years of diverse experience in biotechnology and drug delivery he thrives on complex technical and managerial challenges. In his 16 years at Amgen John has demonstrated expertise in leading geographically diverse cross functional teams, and developing strategy for new technologies as well as commercialized products. He serves on the University of Rhode Island College of Environmental & Life Sciences Dean’s Advisory Council; and Bio Science Leaders Forum. Prior to joining Amgen, John was a Research Scientist at Alkermes Inc., where he contributed to the development of novel drug delivery systems and authored several publications and patents in the field. John started his career at the Institute of Molecular Biology where he was a founding member of this start-up Biotech Company which was working to develop soft tissue, bone and nerve regeneration therapies.